Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,877 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two new susceptibility loci 1q24.2 and 11p11.2 confer risk to severe acne.
He L, Wu WJ, Yang JK, Cheng H, Zuo XB, Lai W, Gao TW, Ma CL, Luo N, Huang JQ, Lu FY, Liu YQ, Huang YJ, Lu QJ, Zhang HL, Wang L, Wang WZ, Wang MM, Xiao SX, Sun Q, Li CY, Bai YP, Li H, Zhou ZC, Zhou FS, Chen G, Liang B, Qi J, Yang XY, Yang T, Zheng X, Sun LD, Zhang XJ, Zhang YP. He L, et al. Among authors: sun q, sun ld. Nat Commun. 2014;5:2870. doi: 10.1038/ncomms3870. Nat Commun. 2014. PMID: 24399259 Free article.
Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial.
Liu LF, Chen JS, Gu J, Xu JH, Jin HZ, Pang XW, Wang G, Yu C, Song ZQ, Guo ZP, Li W, Lai W, Cui PG, Chen M, Fang H, Lyu CZ, Li YZ, Sun Q, Xie HF, Liu XM, Gao XH, Shi YL, Zhao NQ, Zhang W, Zheng M. Liu LF, et al. Among authors: sun q. Arch Dermatol Res. 2020 Aug;312(6):437-445. doi: 10.1007/s00403-019-02024-6. Epub 2019 Dec 23. Arch Dermatol Res. 2020. PMID: 31873772 Clinical Trial.
A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum.
Jin H, Huang T, Wu R, Zhao M, Wu H, Long H, Yin H, Liao J, Luo S, Liu Y, Zhang Q, Zhang P, Tan Y, Luo S, Huang X, Deng Y, Liao W, Duan L, Chen J, Zhou Y, Yin J, Qiu H, Yuan J, Wang Z, Li M, Wu X, Chen L, Cai L, Huang C, Li Q, Tang B, Yu B, Li X, Gao X, Hu Y, Ren X, Xue H, Wei Z, Chen J, Li F, Ling G, Luo H, Zhao H, Yang S, Cui Y, Lin Y, Yao X, Sun L, Guo Q, Fang H, Zeng K, Deng D, Zhang J, Li Y, Pu X, Liao X, Dang X, Huang D, Liang Y, Sun Q, Xie H, Zeng L, Huang C, Diao Q, Tao J, Yu J, Li Z, Xu H, Li H, Lai W, Liu X, Wu J, Li T, Lei T, Sun Q, Li Y, Zhang G, Huang X, Lu Q. Jin H, et al. Among authors: sun l, sun q. Lupus. 2020 Dec;29(14):1854-1865. doi: 10.1177/0961203320959716. Epub 2020 Oct 7. Lupus. 2020. PMID: 33028176
A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.
Yu C, Zhang F, Ding Y, Li Y, Zhao Y, Gu J, Guo S, Pan W, Jin H, Sun Q, Kang X, Yang Q, Jiang X, Song Z, Lu Q, Pang X, Kuang Y, Deng D, Li Y, Zhang C, Tao J, Xie L, Wang Y, Wang J, Wang G. Yu C, et al. Among authors: sun q. Int Immunopharmacol. 2022 Nov;112:109248. doi: 10.1016/j.intimp.2022.109248. Epub 2022 Sep 18. Int Immunopharmacol. 2022. PMID: 36126411 Clinical Trial.
14,877 results
You have reached the last available page of results. Please see the User Guide for more information.